Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
942 GBX | -0.63% | -3.88% | +5.37% |
Mar. 26 | Biotech Group Acquisition Withdraws IPO | DJ |
2023 | Biotech Growth's total return underperforms benchmark in tough market | AN |
Sales 2022 | -205M -254M | Sales 2023 | -32.42M -40.22M | Capitalization | 303M 376M |
---|---|---|---|---|---|
Net income 2022 | -202M -251M | Net income 2023 | -41M -50.87M | EV / Sales 2022 | -1.96 x |
Net Debt 2022 | 31.74M 39.38M | Net Debt 2023 | 17.4M 21.59M | EV / Sales 2023 | -9.89 x |
P/E ratio 2022 |
-1.84
x | P/E ratio 2023 |
-7.64
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99.65% |
1 day | -0.63% | ||
1 week | -3.88% | ||
Current month | -5.33% | ||
1 month | -1.88% | ||
3 months | +6.80% | ||
6 months | +23.14% | ||
Current year | +5.37% |
Members of the board | Title | Age | Since |
---|---|---|---|
Geoffrey Hsu
BRD | Director/Board Member | - | 18-05-15 |
Roger Yates
CHM | Chairman | 67 | 21-11-30 |
Steve Bates
BRD | Director/Board Member | 66 | 15-07-07 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-18 | 942 | -0.63% | 88,682 |
24-04-17 | 948 | -1.96% | 33,417 |
24-04-16 | 967 | -0.92% | 125,867 |
24-04-15 | 976 | -1.51% | 43,033 |
24-04-12 | 991 | +1.12% | 44,339 |
Delayed Quote London S.E., April 18, 2024 at 11:35 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+5.37% | 395M | |
+2.00% | 14.2B | |
+1.14% | 6.09B | |
+11.18% | 4.39B | |
+8.81% | 4.24B | |
-10.23% | 3.93B | |
-3.08% | 3.22B | |
+8.55% | 3.19B | |
+6.21% | 3.01B | |
+9.32% | 2.74B |
- Stock Market
- Equities
- BIOG Stock